`____________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`____________
`
`BLUEBIRD BIO, INC.,
`Petitioner,
`
`v.
`
`SLOAN KETTERING INSTITUTE FOR CANCER RESEARCH,
`Patent Owner.
`____________
`Case No. IPR2023-00074
`Patent No. 8,058,061
`____________
`
`
`
`
`EXCLUSIVE LICENSEE SAN ROCCO THERAPEUTICS, LLC’S
`
`POWER OF ATTORNEY
`
`
`
`
`
`
`
`
`Case IPR2023-00074
`Patent 8,058,061
`
`
`
`Exclusive licensee and real party-in-interest, San Rocco Therapeutics, LLC
`(“SRT”), hereby appoints the practitioners associated with Fox Rothschild LLP,
`Customer Number 29880, including the following lead and back-up counsel, as its
`attorneys to transact all business in the United States Patent & Trademark Office
`associated with an inter partes review of U.S. Patent No. 8,058,061.
`
`Lead Counsel
`Michael W. Glynn (Reg. No. 76,729)
`mglynn@foxrothschild.com
`Fox Rothschild LLP
`101 Park Avenue, 17th Floor
`New York, NY 10178
`Telephone: (212) 878-7900
`Facsimile: (212) 692-0940
`
`
`Backup Counsel
`Wanda French-Brown (pro hac vice)
`wfrench-brown@foxrothschild.com
`Fox Rothschild LLP
`101 Park Avenue, 17th Floor
`New York, NY 10178
`Telephone: (212) 878-7900
`Facsimile: (212) 692-0940
`
`
`Backup Counsel
`James H. McConnell (pro hac vice)
`jmcconnell@foxrothschild.com
`Fox Rothschild LLP
`101 Park Avenue, 17th Floor
`New York, NY 10178
`Telephone: (212) 878-7900
`Facsimile: (212) 692-0940
`
`
`
`
`Backup Counsel
`Joe Chen (Reg. No. 70,066)
`joechen@foxrothschild.com
`Fox Rothschild LLP
`997 Lenox Drive
`Lawrenceville, NJ 08648
`Telephone: (609) 844-3024
`Facsimile: (609) 896-1469
`
`Backup Counsel
`Howard S. Suh (pro hac vice)
`hsuh@foxrothschild.com
`Fox Rothschild LLP
`101 Park Avenue, 17th Floor
`New York, NY 10178
`Telephone: (212) 878-7900
`Facsimile: (212) 692-0940
`
`
`
`
`
`1
`
`
`
`Case IPR2023-00074
`Patent 8,058,061
`
`
`
`The undersigned is authorized to sign on behalf of SRT.
`
`
`
`For: San Rocco Therapeutics, LLC
`
`Signature: ___________________
`
`Name: ______________________
`
`Title: _______________________
`
`Date: _______________________
`
`
`
`
`
`2
`
`Patrick Girondi
`
`Founder/CEO, San Rocco Therapeutics
`
`June 12, 2023
`
`
`
`Case IPR2023-00074
`Patent 8,058,061
`
`
`
`CERTIFICATE OF SERVICE
`Pursuant to 37 CFR § 42.6(e), the undersigned hereby certifies that on June
`
`12, 2023, the foregoing Patent Owner’s Updated Mandatory Notice was served via
`
`e-mail, as authorized by the Petitioner, at the following email correspondence
`
`address of record:
`
`
`
`
`
`Naveen Modi
`Daniel Zeilberger
`PAUL HASTINGS LLP
`2050 M Street NW
`Washington, D.C. 20036
`bluebird-IPR-PH@paulhastings.com
`
`Eric W. Dittmann
`Max H. Yusem
`Krystina L. Ho
`PAUL HASTINGS LLP
`200 Park Avenue
`New York, NY 10166
`bluebird-IPR-PH@paulhastings.com
`
`Dated:
`
`
`
`
`
`Joe Chen
`/s/
`Joe Chen, Ph.D. (Reg. No. 70,066)
`Counsel for San Rocco Therapeutics, LLC, on
`behalf of Sloan Kettering Institute for Cancer
`Research
`
`
`3
`
`